Anti-factor xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis

Obstet Gynecol. 2009 Mar;113(3):740. doi: 10.1097/AOG.0b013e31819b3b38.

Authors

Ingrid Pabinger¹, Andreas Greinacher

Affiliation

¹ Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria (Pabinger) Department of Transfusion Medicine, Institute for Immunology and Transfusion Medicine, University of Greifswald, Greifswald, Germany (Greinacher).

PMID: 19300343
DOI: 10.1097/AOG.0b013e31819b3b38

No abstract available

Publication types

Comment
Letter

MeSH terms

Anticoagulants / therapeutic use*
Antithrombin III / analysis*
Female
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Pregnancy
Pregnancy Complications, Cardiovascular / blood
Pregnancy Complications, Cardiovascular / prevention & control*
Venous Thromboembolism / blood
Venous Thromboembolism / prevention & control*

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Antithrombin III